WO1999002177A1 - Pharmazeutische zusammensetzung enthaltend peptichemio - Google Patents
Pharmazeutische zusammensetzung enthaltend peptichemio Download PDFInfo
- Publication number
- WO1999002177A1 WO1999002177A1 PCT/CH1998/000300 CH9800300W WO9902177A1 WO 1999002177 A1 WO1999002177 A1 WO 1999002177A1 CH 9800300 W CH9800300 W CH 9800300W WO 9902177 A1 WO9902177 A1 WO 9902177A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sarcolysyl
- cyclodextrin
- composition according
- pharmaceutical composition
- fluorophenylalanyl
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
Definitions
- a complex of six peptides containing mL-sarcolysin has become known under the trade name "Peptichemio” (Istituto Sieroterapico Milanese S. Belfanti, Milano, IT) for chemotherapy against cancer. It has been found that the activity of the individual peptides differs and that one representative in particular has a very high toxicity for melanoma cells.
- the peptides are a development that is associated with the product
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98929194A EP1001799B1 (de) | 1997-07-07 | 1998-07-07 | Pharmazeutische zusammensetzung enthaltend peptichemio |
DE59801987T DE59801987D1 (de) | 1997-07-07 | 1998-07-07 | Pharmazeutische zusammensetzung enthaltend peptichemio |
AU79049/98A AU7904998A (en) | 1997-07-07 | 1998-07-07 | Pharmaceutical composition containing peptichemio |
JP2000501767A JP2001509487A (ja) | 1997-07-07 | 1998-07-07 | ペプチケミオを含有する薬剤学的組成物 |
IL13392898A IL133928A0 (en) | 1997-07-07 | 1998-07-07 | Pharmaceutical composition containing peptichemio |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH165197 | 1997-07-07 | ||
CH1651/97 | 1997-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999002177A1 true WO1999002177A1 (de) | 1999-01-21 |
Family
ID=4215447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CH1998/000300 WO1999002177A1 (de) | 1997-07-07 | 1998-07-07 | Pharmazeutische zusammensetzung enthaltend peptichemio |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030162721A1 (de) |
EP (2) | EP1001799B1 (de) |
JP (1) | JP2001509487A (de) |
AU (1) | AU7904998A (de) |
DE (2) | DE59801987D1 (de) |
IL (1) | IL133928A0 (de) |
WO (1) | WO1999002177A1 (de) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000031119A1 (de) * | 1998-11-19 | 2000-06-02 | Ptc Pharma Ag | Verfahren zur herstellung von l-prolyl-l-m-sarcolysyl-l-p-fluorphenylalanin und von derivaten davon |
JP2003533466A (ja) * | 2000-05-18 | 2003-11-11 | ツェンタリス アクチエンゲゼルシャフト | ペプチドの薬剤適用形、その製造法及び使用 |
WO2004000365A1 (en) * | 2002-06-24 | 2003-12-31 | Ghanem Elias Ghanem | Drug transport and delivery system |
WO2004024755A2 (de) * | 2002-08-29 | 2004-03-25 | Lipal Biochemicals Ag | Sarcolysyl-derivate und verfahren zu deren herstellung |
US11603385B2 (en) | 2017-06-24 | 2023-03-14 | Cytogel Pharma, Llc | Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008512490A (ja) * | 2004-09-08 | 2008-04-24 | チェルシー・セラピューティクス,インコーポレイテッド | 異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤 |
MX2010010998A (es) * | 2008-04-07 | 2011-01-25 | Chelsea Therapeutics Inc | Composiciones de antifolato. |
MX357677B (es) | 2009-05-29 | 2018-07-19 | Cydex Pharmaceuticals Inc | Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de fabricación y uso de las mismas. |
US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
WO2011005832A1 (en) * | 2009-07-08 | 2011-01-13 | Chelsea Therapeutics, Inc. | Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl] -benzoylamino} -4-methylenξ-penta nedioic acid |
EP2496237A2 (de) * | 2009-11-06 | 2012-09-12 | Chelsea Therapeutics, Inc. | Enzymhemmende verbindungen |
US20110237609A1 (en) * | 2010-03-29 | 2011-09-29 | Chelsea Therapeutics, Inc. | Antifolate compositions |
WO2012078708A1 (en) | 2010-12-07 | 2012-06-14 | Chelsea Therapeutics, Inc. | Combination comprising methotrexate and an antifolate compound |
ES2969958T3 (es) * | 2017-11-30 | 2024-05-23 | Cytogel Pharma Llc | Formulaciones farmacéuticas analgésicas novedosas y usos de las mismas |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2094175A1 (en) * | 1970-06-11 | 1972-02-04 | Istituto Sieroterapic | Antitumour oligopeptides - contg meta-(di-(2-chloroethyl)-amino)-l-ph |
FR2101226A1 (de) * | 1970-08-05 | 1972-03-31 | Sclavo Inst Sieroterapeut | |
WO1994020136A1 (en) * | 1993-03-08 | 1994-09-15 | Department Of The Army, United States Government | Cyclodextrin-peptide compositions |
-
1998
- 1998-07-07 US US09/462,155 patent/US20030162721A1/en not_active Abandoned
- 1998-07-07 DE DE59801987T patent/DE59801987D1/de not_active Expired - Fee Related
- 1998-07-07 DE DE59810043T patent/DE59810043D1/de not_active Expired - Fee Related
- 1998-07-07 WO PCT/CH1998/000300 patent/WO1999002177A1/de active IP Right Grant
- 1998-07-07 EP EP98929194A patent/EP1001799B1/de not_active Expired - Lifetime
- 1998-07-07 EP EP01201272A patent/EP1132395B1/de not_active Expired - Lifetime
- 1998-07-07 AU AU79049/98A patent/AU7904998A/en not_active Abandoned
- 1998-07-07 IL IL13392898A patent/IL133928A0/xx unknown
- 1998-07-07 JP JP2000501767A patent/JP2001509487A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2094175A1 (en) * | 1970-06-11 | 1972-02-04 | Istituto Sieroterapic | Antitumour oligopeptides - contg meta-(di-(2-chloroethyl)-amino)-l-ph |
FR2101226A1 (de) * | 1970-08-05 | 1972-03-31 | Sclavo Inst Sieroterapeut | |
WO1994020136A1 (en) * | 1993-03-08 | 1994-09-15 | Department Of The Army, United States Government | Cyclodextrin-peptide compositions |
Non-Patent Citations (2)
Title |
---|
ASTALDI: "Peptichemio: a multifaceted antiblastic drug", WADLEY MEDICAL BULLETIN, vol. 5, no. 3, 1975, pages 303 - 326, XP002079526 * |
RAJEWSKI ET AL.: "Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 85, no. 11, November 1996 (1996-11-01), pages 1142 - 1168, XP000629515 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000031119A1 (de) * | 1998-11-19 | 2000-06-02 | Ptc Pharma Ag | Verfahren zur herstellung von l-prolyl-l-m-sarcolysyl-l-p-fluorphenylalanin und von derivaten davon |
US6767992B1 (en) * | 1998-11-19 | 2004-07-27 | Ptc Pharma Ag | Method for producing L-prolyl-L-M-sarcolysyl-L-p-fluorophenylalanine and derivatives thereof |
JP2003533466A (ja) * | 2000-05-18 | 2003-11-11 | ツェンタリス アクチエンゲゼルシャフト | ペプチドの薬剤適用形、その製造法及び使用 |
JP2011213733A (ja) * | 2000-05-18 | 2011-10-27 | Aeterna Zentaris Gmbh | ペプチドの薬剤適用形、その製造法及び使用 |
WO2004000365A1 (en) * | 2002-06-24 | 2003-12-31 | Ghanem Elias Ghanem | Drug transport and delivery system |
EP1374907A3 (de) * | 2002-06-24 | 2004-01-07 | Ghanem Elias c/o Institut Jules Bordet Ghanem | Arzneimittel Transport und Abgabesystem |
WO2004024755A2 (de) * | 2002-08-29 | 2004-03-25 | Lipal Biochemicals Ag | Sarcolysyl-derivate und verfahren zu deren herstellung |
WO2004024755A3 (de) * | 2002-08-29 | 2004-11-18 | Lipal Biochemicals Ag | Sarcolysyl-derivate und verfahren zu deren herstellung |
US11603385B2 (en) | 2017-06-24 | 2023-03-14 | Cytogel Pharma, Llc | Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
AU7904998A (en) | 1999-02-08 |
JP2001509487A (ja) | 2001-07-24 |
US20030162721A1 (en) | 2003-08-28 |
DE59810043D1 (de) | 2003-12-04 |
EP1132395B1 (de) | 2003-10-29 |
IL133928A0 (en) | 2001-04-30 |
EP1132395A2 (de) | 2001-09-12 |
DE59801987D1 (de) | 2001-12-06 |
EP1132395A3 (de) | 2002-02-06 |
EP1001799B1 (de) | 2001-10-31 |
EP1001799A1 (de) | 2000-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69733353T2 (de) | Immunsuppressive wirkstoffe und verfahren | |
EP1001799B1 (de) | Pharmazeutische zusammensetzung enthaltend peptichemio | |
EP1594885B1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
DE2549783A1 (de) | Triglyceride mit entzuendungshemmender wirkung | |
DE3207841A1 (de) | Adjuvans-zubereitung | |
AT395853B (de) | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung | |
DE69917684T2 (de) | Betulinsäure-derivate mit antiangiogener wirkung, verfahren zur herstellung solcher derivate und deren verwendung für die behandlung tumorassoziierter angiogenese | |
DE3335891A1 (de) | 2,5-piperazindionderivate, ihre herstellung und ihre pharmazeutische verwendung | |
EP0021184B1 (de) | Sekretinpräparate mit verstärkter und protrahierter Wirkung, Verfahren zu ihrer Herstellung sowie Dihydroxybenzoyl-L-tyrosin | |
EP0100516B1 (de) | 3-Beta-(3'-(Carboxypropionyloxy))-ursa-9(11),12-dien-28-carbonsäure sowie ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0013891B1 (de) | Dipeptide zur Verwendung bei der Heilung von Krankheiten, einige neue Stoffe aus dieser Verbindungsgruppe, Dipeptide enthaltende Arzneimittel und deren Herstellung | |
CH693558A5 (de) | Pharmazeutische Zusammensetzung. | |
DE1906322A1 (de) | Neue alpha-Alkyl-5-hydroxytryptophanester | |
DE4434488A1 (de) | Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung | |
DE2431916B2 (de) | Acetylthio- und/oder Mercaptogruppen enthaltende 17alpha-(2'-Carboxyäthyl)-17beta-ol-lacton-Steroide, diese enthaltende Arzneimittel, Verfahren zur Herstellung derselben sowie entsprechende Brom enthaltende Steroide als Zwischenprodukte | |
EP1129107B1 (de) | Verfahren zur herstellung von l-prolyl-l-m-sarcolysyl-l-p-fluorphenylalanin und von derivaten davon | |
DE1807585C3 (de) | 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel | |
DE2650366B2 (de) | Verwendung eines 5-Fluoruracilderivats | |
DE2238304A1 (de) | Choleretisch wirksame ester bzw. salze von gallensaeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
DE2615129B2 (de) | Tripeptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
DE2006635C (de) | löalpha, 17alpha (propen 2 yhden dioxy) 9 fluor 1 lbeta, 21 dihydroxy Delta hoch 1,4 pregnadiene bzw deren 21 Ester, Verfahren zu ihrer Herstellung und diese als alleinigen Wirkstoff ent haltende pharmazeutische Mittel | |
DE2307795C3 (de) | 11 beta 17alpha, 21 Trihydroxy-6 | |
DE1468681C3 (de) | 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel | |
DE1468919C (de) | 3,11 Dioxo steroid 4,9 diene und ein Verfahren zu ihrer Herstellung | |
DE10029047B4 (de) | Verwendung von Luteolin-7-O-glucuronid als Wirkstoff in einem anticholestatischen Arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 133928 Country of ref document: IL |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM GW HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09462155 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998929194 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998929194 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998929194 Country of ref document: EP |